ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
132.730,36
-0,21%
S&P 500
5.738,17
-0,13%
US Dollar vs BRL
5,4339
0,00%
Bitcoin
65.810,96
-0,10%
Brent Oil
72,01
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Lucid Diagnostics Inc (LUCD)

  7. Lucid Diagnostics Inc (LUCD) Notícias

LUCD

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LUCD
DataHoraFonteTítuloCódigoCompanhia
24/09/202409:01PR Newswire (US)American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestNASDAQ:LUCDLucid Diagnostics Inc
16/09/202417:30PR Newswire (US)PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing RequirementsNASDAQ:LUCDLucid Diagnostics Inc
10/09/202408:56PR Newswire (US)Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressNASDAQ:LUCDLucid Diagnostics Inc
03/09/202408:51PR Newswire (US)Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthNASDAQ:LUCDLucid Diagnostics Inc
20/08/202409:16PR Newswire (US)Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerNASDAQ:LUCDLucid Diagnostics Inc
13/08/202409:16PR Newswire (US)The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerNASDAQ:LUCDLucid Diagnostics Inc
13/08/202409:01PR Newswire (US)PAVmed Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
12/08/202409:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUCDLucid Diagnostics Inc
12/08/202409:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
12/08/202409:07PR Newswire (US)Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
08/08/202409:31PR Newswire (US)Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing EventNASDAQ:LUCDLucid Diagnostics Inc
06/08/202409:15PR Newswire (US)Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer TestingNASDAQ:LUCDLucid Diagnostics Inc
05/08/202409:15PR Newswire (US)Lucid Diagnostics to Participate in Upcoming Investor ConferencesNASDAQ:LUCDLucid Diagnostics Inc
30/07/202409:15PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024NASDAQ:LUCDLucid Diagnostics Inc
29/07/202409:15PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024NASDAQ:LUCDLucid Diagnostics Inc
23/07/202409:01PR Newswire (US)Lucid Diagnostics Announces Record Quarterly EsoGuard® Test VolumeNASDAQ:LUCDLucid Diagnostics Inc
19/07/202410:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LUCDLucid Diagnostics Inc
19/07/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LUCDLucid Diagnostics Inc
12/07/202417:30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LUCDLucid Diagnostics Inc
11/07/202409:31PR Newswire (US)Lucid Diagnostics Launches New Corporate WebsiteNASDAQ:LUCDLucid Diagnostics Inc
02/07/202408:55PR Newswire (US)Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationNASDAQ:LUCDLucid Diagnostics Inc
12/06/202409:05PR Newswire (US)4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer TestingNASDAQ:LUCDLucid Diagnostics Inc
06/06/202410:48Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:LUCDLucid Diagnostics Inc
06/06/202409:40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LUCDLucid Diagnostics Inc
24/05/202418:26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:LUCDLucid Diagnostics Inc
13/05/202421:43PR Newswire (US)PAVmed Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
13/05/202409:00PR Newswire (US)Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
09/05/202422:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
09/05/202422:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
09/05/202408:49PR Newswire (US)Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA RecallNASDAQ:LUCDLucid Diagnostics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:LUCD

Seu Histórico Recente

BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
BOV
PDGR3
PDG REALT ON
BOV
OIBR3
OI ON
BOV
KRSA3
Kora Saude Participacoes... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados